Cyclooxygenase-2 glycosylation is affected by peroxynitrite in endothelial cells: Impact on enzyme activity and degradation
| dc.contributor.author | Eligini, Sonia | |
| dc.contributor.author | Colli, Susanna | |
| dc.contributor.author | Habib, Aida A. | |
| dc.contributor.author | Aldini, G. | |
| dc.contributor.author | Altomare, Alessandra Anna | |
| dc.contributor.author | Banfi, Cristina | |
| dc.contributor.department | Biochemistry and Molecular Genetics | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:38:11Z | |
| dc.date.available | 2025-01-24T11:38:11Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | The exposure of human endothelial cells to 3-morpholinosydnonimine (SIN-1) induced the expression of cyclooxygenase-2 (COX-2) in a dose-and time-dependent manner. Interestingly, after a prolonged incubation (>8 h) several proteoforms were visualized by Western blot, corresponding to different states of glycosylation of the protein. This effect was specific for SIN-1 that generates peroxynitrite and it was not detected with other nitric oxide-donors. Metabolic labeling experiments using35S or cycloheximide suggested that the formation of hypoglycosylated COX-2 was dependent on de novo synthesis of the protein rather than the deglycosylation of the native protein. Moreover, SIN-1 reduced the activity of the hexokinase, the enzyme responsible for the first step of glycolysis. The hypoglycosylated COX-2 induced by SIN-1 showed a reduced capacity to generate prostaglandins and the activity was only partially recovered after immunoprecipitation. Finally, hypoglycosylated COX-2 showed a more rapid rate of degradation compared to COX-2 induced by IL-1α and an alteration in the localization with an accumulation mainly detected in the nuclear membrane. Our results have important implication to understand the effect of peroxynitrite on COX-2 expression and activity, and they may help to identify new pharmacological tools direct to increase COX-2 degradation or to inhibit its activity. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | |
| dc.identifier.doi | https://doi.org/10.3390/antiox10030496 | |
| dc.identifier.eid | 2-s2.0-85102787887 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29006 | |
| dc.language.iso | en | |
| dc.publisher | MDPI | |
| dc.relation.ispartof | Antioxidants | |
| dc.source | Scopus | |
| dc.subject | Cyclooxygenase-2 | |
| dc.subject | Endothelial cell | |
| dc.subject | N-linked glycosylation | |
| dc.subject | Sin-1 | |
| dc.title | Cyclooxygenase-2 glycosylation is affected by peroxynitrite in endothelial cells: Impact on enzyme activity and degradation | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1